tiprankstipranks
Med Biogene Inc (TSE:MBI.H)
:MBI.H
Canadian Market

Med Biogene (MBI.H) Technical Analysis

Compare
4 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
1Neutral
11Bearish
Technical Analysis Consensus
Sell
2Bullish
0Neutral
4Bearish
Moving Average Consensus
Sell
4Bullish
1Neutral
7Bearish
Med Biogene Inc’s (MBI.H) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Med Biogene Inc is a Sell.
Med Biogene Inc’s (MBI.H) 20-Day exponential moving average is 0.02, while Med Biogene Inc’s (MBI.H) share price is <C$0.1, making it a Sell.
Med Biogene Inc’s (MBI.H) 50-Day exponential moving average is 0.02, while Med Biogene Inc’s (MBI.H) share price is <C$0.1, making it a Sell.

Med Biogene (MBI.H) Pivot Points

Feb 23, 2025, 10:09 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Fibonacci
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Med Biogene (MBI.H) Moving Averages

Feb 23, 2025, 10:09 AM
Period
Simple
Exponential
MA5
0.02Buy
0.02Sell
MA10
0.02Buy
0.02Sell
MA20
0.02Neutral
0.02Sell
MA50
0.02Buy
0.02Sell
MA100
0.02Buy
0.02Sell
MA200
0.02Sell
0.03Sell
Med Biogene Inc’s (MBI.H) 10-Day exponential moving average is 0.02, while Med Biogene Inc’s (MBI.H) share price is <C$0.1, making it a Sell.
Med Biogene Inc’s (MBI.H) 100-Day exponential moving average is 0.02, while Med Biogene Inc’s (MBI.H) share price is <C$0.1, making it a Sell.
Med Biogene Inc’s (MBI.H) stock price is <C$0.1 and Med Biogene Inc’s (MBI.H) 50-day simple moving average is 0.02, creating a Buy signal.
Med Biogene Inc’s (MBI.H) stock price is <C$0.1 and Med Biogene Inc’s (MBI.H) 100-day simple moving average is 0.02, creating a Buy signal.
Med Biogene Inc’s (MBI.H) stock price is <C$0.1 and Med Biogene Inc’s (MBI.H) 200-day simple moving average is 0.02, creating a Sell signal.

Med Biogene (MBI.H) Technical Indicators

Feb 23, 2025, 10:09 AM
Name
Value
Implied Action
RSI (14)
28.58
Buy
STOCH (9,6)
0.00
Neutral
STOCHRSI (14)
>-0.01
Buy
MACD (12,26)
>-0.01
Sell
ADX (14)
88.30
Sell
Williams %R
-100.00
Buy
CCI (14)
0.00
Sell
ATR (14)
<0.01
-
Ultimate Oscillator
-9.82
Sell
ROC
0.00
Buy
Med Biogene Inc’s (MBI.H) Relative Strength Index (RSI) is 28.58, creating a Buy signal.
Med Biogene Inc’s (MBI.H) Trend Strength Indicator (ADX) is 88.30, creating a Sell signal.

FAQ

Is MBI.H a Buy, Hold, or Sell?
Based on MBI.H’s technical indicators, MBI.H is a Sell.
    What is MBI.H’s RSI (14)?
    MBI.H’s RSI (14) is 28.58, which suggests MBI.H is a Buy.
      What is MBI.H’s MACD?
      MBI.H’s MACD is >-0.01, which suggests MBI.H is a Sell.
        What is MBI.H’s 5-day moving average?
        MBI.H’s 5-day moving average is 0.02, which suggests MBI.H is a Buy.
          What is MBI.H’s 20-day moving average?
          MBI.H 20-day moving average is 0.02, which suggests MBI.H is a Neutral.
            What is MBI.H’s 50-day moving average?
            MBI.H’s 50-day moving average is 0.02, which suggests MBI.H is a Buy.
              What is MBI.H’s 200-day moving average?
              MBI.H’s 200-day moving average is 0.02, which suggests MBI.H is a Sell.
                What is MBI.H’s Williams % R (14)?
                MBI.H’s Williams % R (14) is -100.00, which suggests MBI.H is a Buy.
                  What is MBI.H’s CCI (14)?
                  MBI.H’s CCI (14) is 0.00, which suggests MBI.H is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis